Five Questions Companies Should Ask Before Making an Innovation-Driven Acquisition
Harvard Business Review
MARCH 28, 2012
But the killer was the Sprint culture, which led Nextel executives to leave soon after the merger, dissipating Nextel's relatively more entrepreneurial influence. In pharma, Johnson & Johnson's 1999 acquisition of Centocor brought in blockbuster biotechnology innovations led by rheumatoid arthritis drug Remicade.
13 
Let's personalize your content